Cite

    Ni, H. et al. (n.d.). Atomoxetine could improve intra-individual variability in drug-naïve adults with attention-deficit/hyperactivity disorder comparably with methylphenidate: A head-to-head randomized clinical trial. Journal of psychopharmacology. pp. 459-467. [Online].